DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 151 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $512,540 | -45.1% | 36,402 | -39.8% | 0.01% | -50.0% |
| Q1 2023 | $934,262 | +149.8% | 60,470 | +165.0% | 0.03% | +136.4% |
| Q4 2022 | $373,938 | -35.1% | 22,815 | -26.7% | 0.01% | -45.0% |
| Q3 2022 | $576,000 | +311.4% | 31,138 | +117.8% | 0.02% | +122.2% |
| Q4 2021 | $140,000 | -88.5% | 14,299 | -51.7% | 0.01% | -89.9% |
| Q1 2020 | $1,220,000 | +141.1% | 29,634 | +264.5% | 0.09% | +196.7% |
| Q4 2019 | $506,000 | +96.1% | 8,131 | +7.1% | 0.03% | +36.4% |
| Q3 2019 | $258,000 | -37.2% | 7,593 | -57.1% | 0.02% | -24.1% |
| Q1 2019 | $411,000 | +102.5% | 17,708 | +243.6% | 0.03% | +107.1% |
| Q2 2018 | $203,000 | – | 5,153 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $72,236,000 | 20.73% |
| SV Health Investors, LLC | 449,951 | $26,871,000 | 18.64% |
| Redmile Group, LLC | 4,978,941 | $297,342,000 | 5.49% |
| Sunesis Advisors, LLC | 96,299 | $5,751,000 | 5.29% |
| Eversept Partners, LP | 418,652 | $25,001,897 | 3.43% |
| Opaleye Management Inc. | 222,000 | $13,081,000 | 2.64% |
| Avoro Capital Advisors LLC | 1,860,000 | $111,079,000 | 2.20% |
| SPHERA FUNDS MANAGEMENT LTD. | 282,965 | $16,899,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 224,359 | $13,399,000 | 1.23% |
| Artal Group S.A. | 650,000 | $38,818,000 | 1.09% |